2/12
08:23 am
dcth
Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call [Yahoo! Finance]
Medium
Report
Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call [Yahoo! Finance]
2/12
08:00 am
dcth
Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call
Medium
Report
Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call
1/27
08:05 am
dcth
Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Medium
Report
Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
1/25
08:22 am
dcth
Returns On Capital Are Showing Encouraging Signs At Delcath Systems (NASDAQ:DCTH) [Yahoo! Finance]
Low
Report
Returns On Capital Are Showing Encouraging Signs At Delcath Systems (NASDAQ:DCTH) [Yahoo! Finance]
1/21
04:01 pm
dcth
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/13
12:37 pm
dcth
Delcath Systems: Stabilizing Fundamentals Justify A Rating Upgrade [Seeking Alpha]
Low
Report
Delcath Systems: Stabilizing Fundamentals Justify A Rating Upgrade [Seeking Alpha]
1/9
12:46 pm
dcth
Delcath Systems (NASDAQ:DCTH) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Delcath Systems (NASDAQ:DCTH) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
1/9
08:05 am
dcth
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
1/4
04:31 pm
dcth
Should New HEPZATO Subgroup Data and Delcath's Targeted Strategy Require Action From DCTH Investors? [Yahoo! Finance]
Low
Report
Should New HEPZATO Subgroup Data and Delcath's Targeted Strategy Require Action From DCTH Investors? [Yahoo! Finance]
1/1
08:34 am
dcth
Delcath Systems publishes results from subgroup analyses of FOCUS study [Yahoo! Finance]
Low
Report
Delcath Systems publishes results from subgroup analyses of FOCUS study [Yahoo! Finance]
12/31
08:17 am
dcth
Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma [Yahoo! Finance]
Low
Report
Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma [Yahoo! Finance]
12/31
08:00 am
dcth
Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma
Low
Report
Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma
12/23
12:39 pm
dcth
Delcath Systems, Inc. (NASDAQ:DCTH) is a favorite amongst institutional investors who own 51% [Yahoo! Finance]
Low
Report
Delcath Systems, Inc. (NASDAQ:DCTH) is a favorite amongst institutional investors who own 51% [Yahoo! Finance]
12/16
10:55 am
dcth
Here's What Hit Delcath Systems (DCTH) in Q3 [Yahoo! Finance]
Low
Report
Here's What Hit Delcath Systems (DCTH) in Q3 [Yahoo! Finance]
12/3
07:02 pm
dcth
Investors in Delcath Systems (NASDAQ:DCTH) have seen splendid returns of 221% over the past three years [Yahoo! Finance]
Medium
Report
Investors in Delcath Systems (NASDAQ:DCTH) have seen splendid returns of 221% over the past three years [Yahoo! Finance]
12/3
04:01 pm
dcth
Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma
Low
Report
Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma
12/2
03:41 pm
dcth
Delcath Systems (NASDAQ:DCTH) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Delcath Systems (NASDAQ:DCTH) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
11/26
02:05 pm
dcth
Delcath Systems (NASDAQ:DCTH) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Delcath Systems (NASDAQ:DCTH) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
11/20
04:30 pm
dcth
Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program [Yahoo! Finance]
Medium
Report
Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program [Yahoo! Finance]
11/20
04:01 pm
dcth
Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program
Medium
Report
Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program
11/20
01:34 pm
dcth
Delcath Systems (NASDAQ:DCTH) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Delcath Systems (NASDAQ:DCTH) had its "sell (d+)" rating reaffirmed by analysts at
Weiss Ratings.